These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Wondergem M; van der Zant FM; Knol RJJ; Burgers AMG; Bos SD; de Jong IJ; Pruim J World J Urol; 2018 Jan; 36(1):27-34. PubMed ID: 29043431 [TBL] [Abstract][Full Text] [Related]
9. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by Pietrzak A; Czepczynski R; Wierzchoslawska E; Cholewinski W Hell J Nucl Med; 2017; 20(3):237-240. PubMed ID: 29177262 [TBL] [Abstract][Full Text] [Related]
10. Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure? Goldstein J; Even-Sapir E; Ben-Haim S; Saad A; Spieler B; Davidson T; Berger R; Weiss I; Appel S; Lawrence YR; Symon Z Am J Clin Oncol; 2017 Jun; 40(3):256-259. PubMed ID: 25319322 [TBL] [Abstract][Full Text] [Related]
12. [Extension study and evaluation of the therapeutic response in a patient with metastatic lung adenocarcinoma using sequential study with ¹⁸F-FDG PET-CT and ¹⁸F-fluoride PET-CT]. Moragas M; Soler M; Riera E; García JR Rev Esp Med Nucl Imagen Mol; 2015; 34(1):45-8. PubMed ID: 24690280 [TBL] [Abstract][Full Text] [Related]
13. ¹⁸F-NaF PET/CT and ¹¹C-Choline PET/CT for the initial detection of metastatic disease in prostate cancer: overview and potential utilization. Koo PJ; David Crawford E Oncology (Williston Park); 2014 Dec; 28(12):1057-62, 1064-5. PubMed ID: 25738199 [TBL] [Abstract][Full Text] [Related]
14. PSMA-Based [(18)F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer. Rowe SP; Macura KJ; Mena E; Blackford AL; Nadal R; Antonarakis ES; Eisenberger M; Carducci M; Fan H; Dannals RF; Chen Y; Mease RC; Szabo Z; Pomper MG; Cho SY Mol Imaging Biol; 2016 Jun; 18(3):411-9. PubMed ID: 27080322 [TBL] [Abstract][Full Text] [Related]
15. Response-to-repeatability of quantitative imaging features for longitudinal response assessment. Lin C; Harmon S; Bradshaw T; Eickhoff J; Perlman S; Liu G; Jeraj R Phys Med Biol; 2019 Jan; 64(2):025019. PubMed ID: 30566922 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance of extraskeletal computed tomography findings on 18F-NaF PET/CT performed for osseous metastatic disease evaluation. Guo HH; Moradi F; Iagaru A Nucl Med Commun; 2016 Sep; 37(9):975-82. PubMed ID: 27111100 [TBL] [Abstract][Full Text] [Related]
17. Metabolic Imaging of Prostate Cancer Reveals Intrapatient Intermetastasis Response Heterogeneity to Systemic Therapy. Morin F; Beauregard JM; Bergeron M; Nguile Makao M; Lacombe L; Fradet V; Fradet Y; Pouliot F Eur Urol Focus; 2017 Dec; 3(6):639-642. PubMed ID: 28753860 [TBL] [Abstract][Full Text] [Related]
20. The Role of 18F-Sodium Fluoride PET/CT Bone Scans in the Diagnosis of Metastatic Bone Disease from Breast and Prostate Cancer. Kulshrestha RK; Vinjamuri S; England A; Nightingale J; Hogg P J Nucl Med Technol; 2016 Dec; 44(4):217-222. PubMed ID: 27634981 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]